Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Bayer to Acquire Animal Health Business from KMG Chemicals, Inc.

By Pharmaceutical Processing | February 16, 2012

Bayer HealthCare LLC, Animal Health Division has announced that they have signed an agreement to acquire the Animal Health business of KMG Chemicals, Inc. This move will further diversify Bayer’s existing insecticides portfolio in the U.S., allowing the company to offer a broader range of actives and forms in addition to its current product portfolio that includes cattle ear tags, pour-ons, dusts, and farm hygiene premise sprays.

“Bayer is committed to the animal health industry and we are excited about providing these established brands to our customers,” said Ian Spinks, President and General Manager for Bayer Animal Health North America. “Acquiring KMG’s extensive line of ectoparasiticides as well as its cattle ear tag product line nicely complements our existing product portfolio giving us the opportunity to offer more robust insecticide solutions to livestock and poultry producers.” Products acquired in the agreement include brands such as the Patriot cattle ear tag and the Rabon and Permectrin insecticides. These products keep farm animals healthy by protecting them from pests that can spread disease. Bayer plans to explore ways to further develop the insecticides market and continue to bring new innovations to this category.

“KMG has undergone significant growth in the last five years, primarily in our electronic chemicals and wood treating chemicals businesses. As a result of this growth, the animal health business no longer fits with the strategic direction of the company and it is not a material contributor to our overall results,” said Neal Butler, President and CEO KMG Chemicals. “However, we strongly believe that our Animal Health products have a promising future. We also believe that Bayer is the best company to help this business realize its potential, and provide the level of service our customers expect and deserve.” Financial terms of the transaction are undisclosed. The agreement closing is expected to happen in the coming weeks. KMG Animal Health revenues for the last four quarters ended October 31, 2011 were $11.4 million.

  

 

Related Articles Read More >

Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE